Ed Remarque

1.6k total citations
17 papers, 1.1k citations indexed

About

Ed Remarque is a scholar working on Immunology, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ed Remarque has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 6 papers in Epidemiology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ed Remarque's work include T-cell and B-cell Immunology (5 papers), Immunotherapy and Immune Responses (4 papers) and Complement system in diseases (4 papers). Ed Remarque is often cited by papers focused on T-cell and B-cell Immunology (5 papers), Immunotherapy and Immune Responses (4 papers) and Complement system in diseases (4 papers). Ed Remarque collaborates with scholars based in Netherlands, United Kingdom and Germany. Ed Remarque's co-authors include Graham Pawelec, Anders Wikby, Qin Ouyang, Wolfgang Wagner, Rafael Solana, Erminia Mariani, Wei Zheng, Daniel Dodoo, Paul Milligan and Michael Theisen and has published in prestigious journals such as The Journal of Immunology, Infection and Immunity and Journal of Leukocyte Biology.

In The Last Decade

Ed Remarque

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ed Remarque Netherlands 14 563 427 247 153 113 17 1.1k
Bernhard Greve Germany 21 734 1.3× 652 1.5× 98 0.4× 185 1.2× 135 1.2× 34 1.6k
Stefan Kastenbauer Germany 23 418 0.7× 233 0.5× 631 2.6× 177 1.2× 210 1.9× 38 1.7k
Tovah N. Shaw United Kingdom 18 877 1.6× 374 0.9× 111 0.4× 256 1.7× 86 0.8× 26 1.4k
Norinne Lacerda‐Queiroz Brazil 17 393 0.7× 223 0.5× 157 0.6× 167 1.1× 44 0.4× 28 826
Sabita Rana Australia 9 303 0.5× 253 0.6× 77 0.3× 80 0.5× 42 0.4× 11 681
Andrew K. Hastings United States 21 352 0.6× 497 1.2× 458 1.9× 186 1.2× 56 0.5× 28 1.3k
Kurt E. Schaecher United States 19 148 0.3× 351 0.8× 110 0.4× 313 2.0× 76 0.7× 30 1.1k
Esther Wilk Germany 20 586 1.0× 86 0.2× 385 1.6× 426 2.8× 46 0.4× 37 1.5k
Beatrix Schumak Germany 16 554 1.0× 95 0.2× 202 0.8× 202 1.3× 36 0.3× 25 1.0k
Chintan Chhatbar Germany 16 373 0.7× 209 0.5× 115 0.5× 206 1.3× 32 0.3× 26 954

Countries citing papers authored by Ed Remarque

Since Specialization
Citations

This map shows the geographic impact of Ed Remarque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ed Remarque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ed Remarque more than expected).

Fields of papers citing papers by Ed Remarque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ed Remarque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ed Remarque. The network helps show where Ed Remarque may publish in the future.

Co-authorship network of co-authors of Ed Remarque

This figure shows the co-authorship network connecting the top 25 collaborators of Ed Remarque. A scholar is included among the top collaborators of Ed Remarque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ed Remarque. Ed Remarque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Younis, Sumera, Christophe Barnier-Quer, Livia Brunner, et al.. (2018). Down selecting adjuvanted vaccine formulations: a comparative method for harmonized evaluation. BMC Immunology. 19(1). 6–6. 8 indexed citations
3.
Philippens, Ingrid H.C.H.M., et al.. (2016). Acceleration of Amyloidosis by Inflammation in the Amyloid-Beta Marmoset Monkey Model of Alzheimer’s Disease. Journal of Alzheimer s Disease. 55(1). 101–113. 65 indexed citations
4.
Osier, Faith, Gareth D. Weedall, Federica Verra, et al.. (2010). Allelic Diversity and Naturally Acquired Allele-Specific Antibody Responses to Plasmodium falciparum Apical Membrane Antigen 1 in Kenya. Infection and Immunity. 78(11). 4625–4633. 49 indexed citations
5.
Cools, H.J.M., et al.. (2009). Benefits of increasing the dose of influenza vaccine in residents of long‐term care facilities: A randomized placebo‐controlled trial. Journal of Medical Virology. 81(5). 908–914. 13 indexed citations
6.
Dodoo, Daniel, Kwadwo Asamoah Kusi, Helena Lamptey, et al.. (2008). Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children. Malaria Journal. 7(1). 142–142. 114 indexed citations
8.
9.
Aspinall, Richard, Jeffrey Pido-Lopez, Nesrina Imami, et al.. (2007). Old Rhesus Macaques Treated with Interleukin-7 Show Increased TREC Levels And Respond Well to Influenza Vaccination. Rejuvenation Research. 10(1). 5–18. 61 indexed citations
10.
Hart, Bert A. ‘t, Herbert Brok, Ed Remarque, et al.. (2005). Suppression of Ongoing Disease in a Nonhuman Primate Model of Multiple Sclerosis by a Human-Anti-Human IL-12p40 Antibody. The Journal of Immunology. 175(7). 4761–4768. 69 indexed citations
11.
Vierboom, Michel, Paul J. Zavodny, Chuan‐Chu Chou, et al.. (2005). Inhibition of the development of collagen‐induced arthritis in rhesus monkeys by a small molecular weight antagonist of CCR5. Arthritis & Rheumatism. 52(2). 627–636. 72 indexed citations
12.
Ouyang, Qin, Wolfgang Wagner, Wei Zheng, et al.. (2004). Dysfunctional CMV-specific CD8+ T cells accumulate in the elderly. Experimental Gerontology. 39(4). 607–613. 139 indexed citations
13.
Polley, Spencer D., Tabitha Mwangi, Clemens H. M. Kocken, et al.. (2004). Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. Vaccine. 23(5). 718–728. 154 indexed citations
14.
Ouyang, Qin, Wolfgang Wagner, Anders Wikby, Ed Remarque, & Graham Pawelec. (2003). Compromised IFN-gamma production in the elderly leads to both acute and latent viral antigen stimulation: contribution to the immune risk phenotype?. European Cytokine Network. 13(4). 2 indexed citations
15.
Ouyang, Qin, Wolfgang Wagner, Anders Wikby, Ed Remarque, & Graham Pawelec. (2003). Compromised interferon gamma (IFN-gamma) production in the elderly to both acute and latent viral antigen stimulation: contribution to the immune risk phenotype?. PubMed. 13(4). 392–4. 31 indexed citations
16.
Pawelec, Graham, Rafael Solana, Ed Remarque, & Erminia Mariani. (1998). Impact of aging on innate immunity. Journal of Leukocyte Biology. 64(6). 703–712. 115 indexed citations
17.
Remarque, Ed & Graham Pawelec. (1998). T-cell immunosenescence and its clinical relevance in man. Reviews in Clinical Gerontology. 8(1). 5–14. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026